Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HyZer: Hyperthermia in Advanced Cervical Cancer
NCT03249519Recruiting
- Sponsor
- FAU Erlangen-Nürnberg Medical Faculty
- Start
- Aug 2017
- Primary completion
- Dec 2094
- Countries
- 1
01
Overview
Randomised, open-label trial, sponsored by FAU Erlangen-Nürnberg Medical Faculty. Primary endpoint: Overall Survival at 5 years. Started Aug 2017; status: recruiting.
Beyond the preview
Go deeper on NCT03249519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03249519.